Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

MimiVax's cancer vaccine for glioblastoma narrowly misses Phase 2b goal

A brain cancer effort more than a decade in the making has culminated in a disappointing study result — but researchers behind it are contending there’s enough of a promising signal to give certain patients with ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 7 October →